0001104659-14-025625.txt : 20140403 0001104659-14-025625.hdr.sgml : 20140403 20140403163205 ACCESSION NUMBER: 0001104659-14-025625 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140401 FILED AS OF DATE: 20140403 DATE AS OF CHANGE: 20140403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ophthotech Corp. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 BUSINESS PHONE: 212-845-8200 MAIL ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PATEL SAMIR CHANDRAKANT CENTRAL INDEX KEY: 0001277966 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 14742595 MAIL ADDRESS: STREET 1: 3 TIMES SQUARE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 a4.xml 4 X0306 4 2014-04-01 0 0001410939 Ophthotech Corp. OPHT 0001277966 PATEL SAMIR CHANDRAKANT C/O OPHTHOTECH CORPORATION ONE PENN PLAZA, 19TH FLOOR NEW YORK NY 10119 1 1 0 0 President Common Stock 2014-04-01 4 S 0 10676 33.98 D 124991 D Common Stock 2014-04-01 4 S 0 6100 34.76 D 118891 D Common Stock 2014-04-01 4 S 0 100 35.70 D 118791 D The sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Representing Person on December 16, 2013. These shares were disposed of in multiple transactions on April 1, 2014 at actual sales prices ranging from $33.50 to $34.45 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. These shares were disposed of in multiple transactions on April 1, 2014 at actual sales prices ranging from $34.51 to $35.41 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Tom Biancardi, as Attorney-in-Fact for Samir Patel 2014-04-03